← All Allogene Therapeutics, INC filings

Allogene Therapeutics, INC Form 4 insider transactions

NASDAQ
ALLO
Allogene Therapeutics, INC
Form 4: Allogene Therapeutics CFO Reports Purchase of Shares Through Trust Account
Allogene Therapeutics CFO Geoffrey M. Parker reports the purchase of 190 shares of common stock through a trust account, with subsequent restrictions placed to prevent future occurrences.